ADTX trade ideas
AditxtScore™ for COVID-19+file for EUA+commercially available Q1Aditxt Introduces AditxtScore™ for COVID-19 and Announces the Completion of Validation Studies by Stanford Blood Center
AditxtScore™ for COVID-19 to be used in detecting antibodies against SARS-CoV-2 antigens
Aditxt plans to file for an Emergency Use Authorization (EUA) followed by a 510(K) application with the U.S. Food and Drug Administration by the end of the current quarter (Q3, 2020).
Additionally, Aditxt is planning its operational capabilities in anticipation of beginning pilot programs utilizing AditxtScore™ for COVID-19 in Q4, 2020 , with the goal of making AditxtScore™ commercially available starting in Q1, 2021 .
finance.yahoo.com
ADTX: Higher price rejection after gap up Higher price rejection after spike up and gap up.
May try to fill the gap.
If confirmed:
PT1 = 5,70$
PT2 = 4,11 (For gap fill)
Short opportunity from 7.8-8.3 in my opinion ADTX will be choppy and consolidating around 7.4-8.3 area, and then it will get a Rug pull
